ATMs May Have Criminals Going for Gold

"The number of attacks on ATMs in S. Africa rose 35% last year."

Thomas Geissler calls his gold coin dispensing automatic teller machines (ATMs) Gold to Go. If his plan to install SA's first such machine at Cape Town's Waterfront comes to fruition, he may find they live up to their name—but not in the way he intends.

His company Geissler C-B-T has already placed 11 such ATMs in Germany Italy, Spain, the United Arab Emirates and the U.S. Mr. Geissler said yesterday he hopes to install an ATM at the Waterfront this year.

The bombing of an Absa ATM yesterday morning in Lyttelton, a suburb of Centurion, highlights the challenge facing the German businessman.

The number of attacks on ATMs in SA rose 35% last year from 2009, an industry body, the South African Banking Risk Information Centre, said yesterday.

While Gauteng and Limpopo have borne the brunt of the robberies, the prospect of a newly minted gold-dispensing ATM may send a few criminals to the Mother City on a working holiday.

"You mark money in an ATM in the event of a bomb, but you can't do that with gold coins," said Alan Demby, chairman of the South African Gold Coin Exchange. "Thieves would just steal the coins and melt them down."

Geissler C-B-T yesterday installed two machines—on the ground and 124th floors of Dubai's Burj Khalifa, the world's tallest building—bringing its world total to 18, spokesman Joe Dreixler said.

The machines take cash or credit card payments and dispense a packaged gold coin in return. Prices, based on spot prices of gold, are updated every 10 minutes.

"We only accept locations with a very high security level—indoor locations only, not accessible by lorry, with security staff in the building," Mr. Dreixler said.

Novavax Shares Shoot 65% Higher on Phase 3 COVID-19 Vaccine Trial's 89.3% Effectiveness
Source: Streetwise Reports (01/29/2021)

Novavax Inc. shares established a new 52-week high after the firm's COVID-19 vaccine demonstrated an 89.3% efficacy rate in a Phase 3 trial in the U.K. and also showed efficacy against the South African variant in a Phase 2b trial.

Abiomed Shares Gain 8% After Firm Announces Record Q3 Revenue of $232 Million
Source: Streetwise Reports (01/28/2021)

Shares of cardiac medical device maker Abiomed Inc. traded higher after the company reported record revenue for Q3/21 despite the impact from COVID-19.

Sorrento Shares Rise 35% After Firm Posts Positive Data from Phase 1b ICU COVID-19 Trial
Source: Streetwise Reports (01/27/2021)

Shares of Sorrento Therapeutics traded higher after the company released positive preliminary results from it of Phase 1b COVI-MSC™ Study for treatment of hospitalized ICU COVID-19 patients.

Junior Mining Sector 'the Best Value in the Space'
Source: Streetwise Reports (01/27/2021)

The StreetSmart Live! Broadcast on Jan. 26, 2021, focused on metals and why now is a good time for investors to be looking at them and the mining space. John Newell, independent analyst and portfolio manager, and John Feneck, mining sector expert and president of Feneck Consulting, addressed the status of the current metals market. CEOs of the three metals-focused companies comprising the Metallic Group of Companies—Group Ten Metals, Metallic Minerals and Granite Creek Copper—discussed their projects.

Vir Shares Climb 48% on Initial Phase 1 Chronic Hepatitis B Trial Data
Source: Streetwise Reports (01/26/2021)

Vir Biotechnology shares traded higher after the company reported data from its Phase 1 Chronic Hepatitis B Study that showed VIR-3434 significantly and rapidly reduced hepatitis B surface antigen.

Aurinia Pharma Shares Open at 52-Week High as FDA Approves Adult Lupus Nephritis Drug
Source: Streetwise Reports (01/25/2021)

Shares of Aurinia Pharmaceuticals traded 30% higher after the company reported that the U.S. Food and Drug Administration approved its LUPKYNIS™ (voclosporin) for use in treating adults with active lupus nephritis.

AzurRx Doses First Two People in Expanded Phase 2b Trial of Cystic Fibrosis Patients
Source: Streetwise Reports (01/22/2021)

AzurRx BioPharma shares traded 45% higher after the firm advised it had dosed the first two patients in its Phase 2b OPTION 2 Extension Study of MS1819 for treatment of exocrine pancreatic insufficiency in patients with cystic fibrosis.

NGL Energy Shares Rise 21% as It Seeks to Raise $2.05 Billion from Senior Secured Note Offering
Source: Streetwise Reports (01/21/2021)

Shares of NGL Energy Partners LP traded higher after the firm made a series of announcements over the past three days regarding an update on financial operations, a settlement with a customer in bankruptcy, a quarterly Class D unit distribution and a $2.05 billion senior secured debt offering.

Explorer Discovers New Gold Mineralization at Abitibi Gold Belt Property
Source: Streetwise Reports (01/21/2021)

iMetal Resources is setting out to see if the multi-million ounce gold resource next door continues onto its Gowganda West property in Ontario.

Gritstone Oncology Licenses LNP Platform from Genevant Sciences to Develop COVID-19 Vaccine
Source: Streetwise Reports (01/20/2021)

Shares of Gritstone Oncology reached a new 52-week high price after the company advised it entered into a non-exclusive licensing agreement with Genevant Sciences to develop and commercialize self-amplifying RNA vaccines for use against SARS-CoV-2.